Literature DB >> 17634895

Cerebrovascular reactivity is impaired in patients with non-insulin-dependent diabetes mellitus and microangiopathy.

Ligia Petrica1, Maxim Petrica, Adrian Vlad, Flaviu Bob, Cristina Gluhovschi, Gheorghe Gluhovschi, Catalin D Jianu, Sorin Ursoniu, Adalbert Schiller, Silvia Velciov, Virginia Trandafirescu, Gheorghe Bozdog.   

Abstract

BACKGROUND: Cerebrovascular reactivity (CVR) is a hemodynamic parameter representing the increase in normal cerebral artery blood flow in response to a vasodilatory stimulus such as hypercapnia. MAIN
PURPOSE: The aim of the study was to assess CVR using transcranial Doppler ultrasound and the breath-holding test (BHT) in normotensive patients with non-insulin-dependent diabetes mellitus (NIDDM). The cerebrovascular response to hypercapnia was evaluated in relation to risk factors for cerebral microangiopathy.
METHODS: The study was carried out in a group of 34 normotensive NIDDM patients and a group of 31 sex- and age-matched normal controls. The NIDDM group was subdivided into 21 patients with microangiopathic complications (Group A, 12 men, 9 women; mean age 58.77 +/- 8.91 years) and 13 patients with no such complications (Group B, 8 men, 5 women; mean age 56.34 +/- 9.83 years). The control group comprised 17 men and 14 women (Group C, mean age 58.43 +/- 6.31 years). Exclusion criteria were hypertension and past or present symptomatic cerebrovascular disease. The BHT consisted of spontaneous hypercapnia induced by holding the breath for 20 seconds. CVR was estimated in relation to the increase in the mean flow velocity (MFV) compared with the basal velocity in both middle cerebral arteries during hypercapnia.
RESULTS: In Group A, the CVR was significantly decreased in 71.42% of patients, whereas in Group B only 30.76% of patients presented with mildly to moderately impaired CVR. Predictors for impaired % increase in the MFV during the BHT demonstrated by univariate regression analysis were: duration of diabetes (r = 0.802; P < 0.0001), fibrinogen (r = 0.574; P < 0.0001), C-reactive protein (r = 0.525; P < 0.001), proteinuria (r = 0.924; P < 0.0001) and serum creatinine (r = 0.969; P < 0.0001). Multivariate regression analysis showed as predictors: duration of diabetes (P < 0.0001), proteinuria (P < 0.0001) and serum creatinine (P < 0.0001).
CONCLUSION: CVR is impaired in normotensive NIDDM patients. These cerebral hemodynamic changes correlate significantly with the duration of DM, parameters of inflammation, proteinuria and serum creatinine.

Entities:  

Mesh:

Year:  2007        PMID: 17634895     DOI: 10.1007/s00508-007-0809-0

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  32 in total

1.  Estimation of cerebrovascular reactivity using transcranial Doppler, including the use of breath-holding as the vasodilatory stimulus.

Authors:  H S Markus; M J Harrison
Journal:  Stroke       Date:  1992-05       Impact factor: 7.914

2.  Lack of gender difference in acetazolamide-induced cerebral vasomotor reactivity in patients suffering from type-1 diabetes mellitus.

Authors:  B Fülesdi; M Limburg; L Oláh; D Bereczki; L Csiba; J Kollár
Journal:  Acta Diabetol       Date:  2001       Impact factor: 4.280

3.  Microalbuminuria, brain vasomotor reactivity, carotid and kidney arterial flow in Type 2 diabetes mellitus.

Authors:  F Gregorio; F Ambrosi; F Carle; M Boemi; M Boscaro; M G Ceravolo; L Evangelisti; E Bordoni; C Sardu
Journal:  Diabetes Nutr Metab       Date:  2004-12

Review 4.  Cerebral autoregulation.

Authors:  O B Paulson; S Strandgaard; L Edvinsson
Journal:  Cerebrovasc Brain Metab Rev       Date:  1990

5.  Impaired response of perforating arteries to hypercapnia in chronic hyperglycemia.

Authors:  Ximena-Sayuri Oizumi; Taichi Akisaki; Yoshiyuki Kouta; Xiu Z Song; Toshihiro Takata; Takeshi Kondoh; Keiji Umetani; Masatsugu Hirano; Katsuhito Yamasaki; Eiji Kohmura; Koichi Yokono; Takashi Sakurai
Journal:  Kobe J Med Sci       Date:  2006

6.  No correlation between impairment of cerebrovascular reserve capacity and electrophysiologically assessed severity of neuropathy in noninsulin-dependent diabetes mellitus.

Authors:  Eszter Hidasi; Miklós Káplár; Péter Diószeghy; Dániel Bereczki; László Csiba; Martien Limburg; Béla Fülesdi
Journal:  J Diabetes Complications       Date:  2002 May-Jun       Impact factor: 2.852

Review 7.  Diabetes mellitus and stroke.

Authors:  I Idris; G A Thomson; J C Sharma
Journal:  Int J Clin Pract       Date:  2006-01       Impact factor: 2.503

8.  Reduced vasomotor reactivity in cerebral microangiopathy : a study with near-infrared spectroscopy and transcranial Doppler sonography.

Authors:  C Terborg; F Gora; C Weiller; J Röther
Journal:  Stroke       Date:  2000-04       Impact factor: 7.914

Review 9.  Stroke in patients with diabetes mellitus.

Authors:  Boris N Mankovsky; Dan Ziegler
Journal:  Diabetes Metab Res Rev       Date:  2004 Jul-Aug       Impact factor: 4.876

10.  Diabetic patients have an impaired cerebral vasodilatory response to hypercapnia under propofol anesthesia.

Authors:  Yuji Kadoi; Hiroshi Hinohara; Fumio Kunimoto; Shigeru Saito; Masanobu Ide; Haruhiko Hiraoka; Fuminori Kawahara; Fumio Goto
Journal:  Stroke       Date:  2003-09-04       Impact factor: 7.914

View more
  8 in total

1.  Transcranial Doppler monitoring may be misleading in prediction of elevated ICP in brain-injured patients.

Authors:  Maria Ahmad; Matthieu Legrand; Anne-Claire Lukaszewicz; Philippe Charlier; Joaquim Mateo; Didier Payen
Journal:  Intensive Care Med       Date:  2013-03-20       Impact factor: 17.440

2.  Obese Adolescents with Type 2 Diabetes Mellitus Have Hippocampal and Frontal Lobe Volume Reductions.

Authors:  Hannah Bruehl; Victoria Sweat; Aziz Tirsi; Bina Shah; Antonio Convit
Journal:  Neurosci Med       Date:  2011-03-01

3.  Type 2 diabetes affects hippocampus volume differentially in men and women.

Authors:  R Hempel; R Onopa; Antonio Convit
Journal:  Diabetes Metab Res Rev       Date:  2012-01       Impact factor: 4.876

4.  Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial.

Authors:  Ligia Petrica; Maxim Petrica; Adrian Vlad; Catalin Dragos Jianu; Gheorghe Gluhovschi; Calina Ianculescu; Victor Dumitrascu; Sorin Giju; Cristina Gluhovschi; Flaviu Bob; Sorin Ursoniu; Florica Gadalean; Silvia Velciov; Gheorghe Bozdog; Roxana Marian
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

5.  Study Protocol: The Heart and Brain Study.

Authors:  Sana Suri; Daniel Bulte; Scott T Chiesa; Klaus P Ebmeier; Peter Jezzard; Sebastian W Rieger; Jemma E Pitt; Ludovica Griffanti; Thomas W Okell; Martin Craig; Michael A Chappell; Nicholas P Blockley; Mika Kivimäki; Archana Singh-Manoux; Ashraf W Khir; Alun D Hughes; John E Deanfield; Daria E A Jensen; Sebastian F Green; Veronika Sigutova; Michelle G Jansen; Enikő Zsoldos; Clare E Mackay
Journal:  Front Physiol       Date:  2021-03-31       Impact factor: 4.566

6.  A high salt meal does not impair cerebrovascular reactivity in healthy young adults.

Authors:  Kamila U Migdal; Austin T Robinson; Joseph C Watso; Matthew C Babcock; Shannon L Lennon; Christopher R Martens; Jorge M Serrador; William B Farquhar
Journal:  Physiol Rep       Date:  2020-10

7.  Evaluation of vasomotor reactivity in systemic lupus erythematosus patients and its comparison with the control group.

Authors:  Fariborz Khorvash; Elham Shirani; Gholam Reza Askari; Seyed Ali Mousavi; Zahra Sayedbonakdar; Alimohammad Fatemi
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

8.  Influence of hypertension and type 2 diabetes mellitus on cerebrovascular reactivity in diabetics with retinopathy.

Authors:  Mira Ivankovic; Maja Radman; Antonela Gverovic-Antunica; Sanda Tesanovic; Gorana Trgo; Vida Demarin
Journal:  Ann Saudi Med       Date:  2013 Mar-Apr       Impact factor: 1.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.